Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Sessions featuring roundtable discussions from the 4th International Workshop on Acute Leukemias (iwAL), which was held in Nice, France, on 16 – 18 September 2022.

Welcome to The AML Sessions brought to you by the Video Journal of Hematological Oncology (VJHemOnc). These exclusive sessions feature roundtable discussions from the 4th International Workshop on Acute Leukemias (iwAL), which was held in Nice, France, on 16 – 18 September 2022.

Our experts discuss several topics, including challenges and novel treatment approaches in acute myeloid leukemia (AML), the use of measurable residual disease (MRD) in clinical practice, and mechanisms of drug resistance.

Click on one of the videos below to discover our new video player!

View all iwAL 2022 presentations
View The ALL Sessions from iwAL 2022

Standard of care in AML in 2022

What is the next AML blockbuster?

What do we know about drug resistance?

Immunotherapeutics in AML

Current challenges in clinical genomics

 

 

Enduring Content from iwAL 2022 was supported by:

 

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals